BCCA Protocol Summary for Adjuvant …
BCCA Protocol Summary for Adjuvant Chemotherapy for Resected Pancreatic AdenocarcinomaUsing Capecitabine and Gemcitabine . Protocol Code GIPAJGCAP Tumour Group Gastrointestinal Contact Physician GI Systemic Therapy . ELIGIBILITY:
Download BCCA Protocol Summary for Adjuvant …
Information
Domain:
Source:
Link to this page:
Documents from same domain
Oncology Nutrition High Protein High Energy …
www.bccancer.bc.caHigh Protein High Energy Food Choices 3 Examples of High Protein Foods • All meat (eg. beef, pork, goat, lamb) • Fish and shellfish • All poultry (eg. chicken, turkey, duck)
BC CANCER HAZARDOUS DRUG LIST
www.bccancer.bc.caBC CANCER HAZARDOUS DRUG LIST (Refer to: Pharmacy Directive VI-80 Hazardous Drug List) The BC Cancer Hazardous Drug List (BC Cancer HD List) is comprised of:
Safe Handling of Hazardous Drugs - BC Cancer
www.bccancer.bc.caA.1 Potential Hazards of Handling Hazardous Drugs..... 1 A.2 Hazardous Drug List.....
“Magic” mouthwash explained - BC Cancer
www.bccancer.bc.caFAMILY PRACTICE ONCOLOGY NETWORK JOURNAL / FALL 2014 3 “Magic” mouthwash explained By Dr. Allan Hovan, Provincial Professional Practice Leader,
Symptom Management Guidelines: ORAL …
www.bccancer.bc.caSymptom Management Guidelines: ORAL MUCOSITIS . Definition Oral Mucositis (Stomatitis): An acute inflammation and/or ulceration of the …
Guidelines for Management of CID - BC Cancer
www.bccancer.bc.caDisclaimer Both the format and content of the guidelines will change as they are reviewed and revised on a periodic basis. Any physician using these guidelines to provide
British Columbia Cancer Agency POLICY
www.bccancer.bc.caBritish Columbia Cancer Agency ¦ POLICY Title: PREVENTION AND MANAGEMENT OF EXTRAVASATION OF CHEMOTHERAPY Number: III-20 Effective Date: Provincial Systemic Program September 1,1997
Symptom Management Guidelines: FEVER AND …
www.bccancer.bc.caSymptom Management Guidelines: FEVER AND NEUTROPENIA . Definition • Fever: A single oral temperature of ≥ 38.3° C (101° F) OR a temperature ≥ 38 ° C (100.4 ° F) which lasts more than 1h
Symptom Management Guidelines: XEROSTOMIA
www.bccancer.bc.caSymptom Management Guidelines: XEROSTOMIA. Definition(s) • Xerostomia: abnormal dryness in the mouth characterized by a marked decrease and/or thickening of saliva, may be
Linking the BC Psychosocial Community Oncology …
www.bccancer.bc.caCarolyn Jacob - New Regional Professional Practice Leader at the Centre for the North. We welcome Carolyn Jacob, MSW, RSW to her new role at the BC
Related documents
GALLSTONES: HERE S WHAT THE DOCTOR WON T …
www.chem-tox.comGALLSTONES: HERE’S WHAT THE DOCTOR WON’T TELL YOU! by Penny Samuels You have a terrible pain and tenderness in the upper right …
Pathophysiology of Gallstone Formation and …
www.columbia.edu1 S.N.S Pathophysiology of Gallstone Formation and Pancreatitis Robert F. Schwabe rfs2102@columbia.edu S.N.S Pancreatic secretions and bile are required for digestion
ACG Clinical Guideline: Diagnosis and Management …
gi.orgElta et al. The American Journal of GASTROENTEROLOGY VOLUME XXX | XXX 2018 www.nature.com/ajg 2 Management decisions for pancreatic cysts must …
As of October 1, the Joint Federal Travel …
www.defensetravel.dod.milAs of October 1, the Joint Federal Travel Regulations, Volume 1 (JFTR) and the Joint Travel Regulations, Volume2 (JTR) officially merged into a single set of
ESPEN Guidelines on Enteral Nutrition: Pancreas
espen.infoARTICLE IN PRESS Indications More than 80% of patients can be treated adequately with normal food supplemented by pancreatic enzymes. B 2.4 10–15% of all patients require oral nutritional
Pancreatic cancer: What defines resectabilityWhat …
www.gicancers.orgPancreatic cancer: What defines resectabilityWhat defines resectability and the role for surgery Douglas B. Evans For the Multidisciplinary PancreaticFor the Multidisciplinary Pancreatic
Pancreatic Cancer - kirkpatrickfamilycare.com
kirkpatrickfamilycare.comPancreatic Cancer By Richard A. Kirkpatrick, MD Reference: http://cme.medscape.com/viewarticle/702303?src=cmemp Last month, pancreatic cancer took yet another former ...
OCTREOTIDE IN THE PREVENTION AND …
www.surgicalcriticalcare.net3 Approved 06/20/2005 Revised 10/06/2009 There was also no statistical difference in significant complications caused by pancreatic drainage (20% in the octreotide group and 36% in the placebo group, P = 0.64).
OCTREOTIDE IN THE PREVENTION AND …
www.surgicalcriticalcare.net2 Approved 6/20/05 secreting tumors (2). Octreotide has a longer half-life than somatostatin which allows for intermittent subcutaneous injections rather than a continuous intravenous infusion (1,2).